About Aeglea Therapeutics, Inc. (adapted from Aeglea Therapeutics, Inc. prospectus):
They are a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism that they believe will transform the lives of patients with inborn errors of metabolism and cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.